Molecular Analysis of the <i>SRD5A2</i> in 46,XY Subjects With Incomplete Virilization: The P212R Substitution of the Steroid 5α‐Reductase 2 May Constitute an Ancestral Founder Mutation in Mexican Patients

DOI Web Site Web Site 1 Citations

Search this article

Description

<jats:p><jats:bold>ABSTRACT: </jats:bold> Inactivating mutations of the <jats:italic>SRD5A2</jats:italic> gene result in steroid 5α‐reductase 2 deficiency, an autosomal recessive disorder expressed as a male‐limited disorder of sex development. Herein, genomic DNA was isolated from 11 new patients with apparent steroid 5α‐reductase 2 deficiency. Coding sequence abnormalities in SRD5A2 were assessed by exon‐specific polymerase chain reaction, single‐stranded conformation polymorphism, and direct sequencing. Likewise, enzymatic activity of the P212R gene variant of SRD5A2 was assessed. DNA analysis revealed mutations in all patients (G115D, R171S, N193S, E197D, G203S, P212R). Three individuals were compound heterozygotes, 6 were homozygotes, and 2 more were single heterozygotes for <jats:italic>SRD5A2</jats:italic> mutations; remarkably, 40% of the mutant alleles (9/22) contained the gene variant P212R. The results described in this study represent, along with our previous reports, the largest number of patients with steroid 5α‐reductase 2 deficiency belonging to nonrelated families. Regarding the frequency of the p.P212R mutation in our population and its presence throughout all of our country, it allows us to hypothesize that the presence of this mutation may constitute a founder gene effect.</jats:p>

Journal

Citations (1)*help

See more

Report a problem

Back to top